Effects of morin on an experimental model of acute colitis in rats

Pharmacology

Volumn 57, Issue 5, 1998, Pages 261-270

  Ocete, M Angeles ^a   Gálvez, Julio ^a   Crespo, M Esperanza ^a   Cruz, Torcuata ^a   González, Mercedes ^a   Torres, M Isabel ^a   Zarzuelo, Antonio ^a  

^a UNIVERSITY OF GRANADA   (Spain)

Author keywords

Antioxidant activity; Experimental colitis; Intestinal anti inflammatory activity; Morin

Indexed keywords

FLAVONOID; GLUTATHIONE; LEUKOTRIENE B4; MALONALDEHYDE; MORIN; MYELOPEROXIDASE; TRINITROBENZENESULFONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; COLITIS; COLON ABSORPTION; COLON MUCOSA; CONTROLLED STUDY; EXPERIMENTAL MODEL; FEMALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

ACUTE DISEASE; ADMINISTRATION, ORAL; ANIMALS; ANTIOXIDANTS; COLITIS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLAVONOIDS; LEUKOTRIENE B4; MALONDIALDEHYDE; RATS; RATS, WISTAR; TRINITROBENZENESULFONIC ACID;

EID: 0031709701     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000028250     Document Type: Article

References (34)

1. Elson CO: The basis of current and future therapy for inflammatory bowel disease. Am J Med 1996;100: 656-662.
2. Shanahan F, Targan SR: Mechanisms of tissue injury in inflammatory bowel disease; in Targan SR, Shanahan F (eds): Inflammatory Bowel Disease: From Bench to Bedside. Baltimore, Williams & Wilkins, 1994, pp 78-88.
3. Harris ML, Schiller HJ, Reilly PM, Donowitz M, Grisham MB, Bulkley GB: Free radicals and other reactive oxygen metabolites in inflammatory bowel disease: Cause, consequence or epiphenomenon? Pharmacol Ther 1992;53:375-408.
4. Havsteen B: Flavonoids, a class of j natural products of high pharmacological potency. Biochem Pharmacol 1983;32:1141-1148.
5. Mora A, Payá M, Rios JL, Alcaraz MJ: Structure-activity relationships of polymethoxyflavones and other flavonoids as inhibitors of non-enzymic lipid peroxidation. Biochem Pharmacol 1990;40:793-797.
6. Middleton E, Kandaswami C: Plant flavonoid modulation of immune and inflammatory cell functions; in Klurfeld DM (ed): Human Nutrition: A Comprehensive treatise. Vol 8: Nutrition and Immunology. New York, Plenum Press, 1993, pp 239-266.
7. Sánchez de Medina F, Gálvez J, Romero JA, Zarzuelo A: Effect of quercitrin on acute and chronic experimental colitis in the rat. J Pharmacol Exp Ther 1996;278:771-779.
8. Gálvez J, Cruz T, Crespo E, Ocete MA, Lorente MD, Sanchez de Medina F, Zarzuelo A: Rutoside as mucosal protective in acetic acid-induced rat colitis. Planta Med 1997;63: 409-414.
9. 4-induced microsomal lipid peroxidation. Experientia 1991;47:195-199.
10. Pagonis C, Tauber AI, Pavlotsky N, Simons ER: Flavonoid impairment of neutrophil response. Biochem Pharmacol 1986;35:237-245.
11. Wu T-W, Zeng L-H, Wu J, Fung KP: Morin hydrate is a plant-derived and antioxidant-based hepato-protector. Life Sci 1993:53:PL213-PL218.
12. Wu T-W, Fung KP, Zeng L-H, Wu J, Hempel A, Grey AA, Camerman N: Molecular properties and myocardial salvage effects of morin hydrate. Biochem Pharmacol 1995;49: 537-543.
13. Elson CO, Sartor B, Tennyson GS, Riddell RH: Experimental models of inflammatory bowel disease. Gastroenterology 1995;109:1344-1367.
14. Morris GP, Beck PL, Herridge W, Depew W, Szewczuk MR, Wallace JL: Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 1989;96:795-803.
15. Bell CJ, Gall DG, Wallace JL: Disruption of colonic electrolyte transport in experimental colitis. Am J Physiol 1995;268:G622-G630.
16. Krawisz JE; Sharon P, Stenson WF: Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 1984;87: 1344-1350.
17. Anderson ME: Determination of glutathione and glutathione disulfide in biological samples. Methods Enzymol 1985;113:548-555.
18. Esterbauer H, Cheeseman KH: Determination of aldehydic lipid peroxidation products: Malonaldehyde and 4-hydroxynonenal. Methods Enzymol 1990;186:407-421.
19. McCafferty DM, Rioux K, Wallace JL: Granulocyte infiltration in experimental colitis in the rat is interleukin-1 dependent and leukotriene independent. Eicosanoids 1992;5: 121-125.
20. Veljaca M, Lesch CA, Pllana R, Sanchez B, Chan K, Guglietta A: BPC-15 reduces trinitrobenzene sulfonic acid-induced colonie damage in rats. J Pharmacol Exp Ther 1995; 272:417-422.
21. Yamada T, Marshall S, Specian RD, Grisham MB: A comparative study of two models of experimental colitis in rats. Gastroenterology 1992; 102:1524-1534.
22. McHugh KJ, Svensjö E, Persson CGA: Exudative and absorptive permeability in different phases of an experimental colitis condition. Scand J Gastroenterol 1996;31: 900-905.
23. Wallace JL: 5-Lipoxygenase: A rational target for therapy on inflammatory bowel disease? Trends Pharmacol Sci 1990;11:51-53.
24. Cui N, Friend DR, Fedorak RN: A budenoside prodrug accelerates treatment of colitis in rats. Gut 1994;35:1439-1446.
25. Bertran X, Mañe J, Fernandez-Bañares F, Castella E, Bartoli R, Ojanguren I, Esteve M, Gassull MA: Intracolonic administration of zileuton, a selective 5-lipoxygenase inhibitor, accelerates healing in a rat model of chronic colitis. Gut 1996; 38:899-904.
26. Wallace JL, MacNaughton WK, Morris GP, Beck PL: Inhibition of leukotriene synthesis markedly accelerate healing in a fat model of inflammatory bowel disease. Gastroenterology 1989;96:29-36.
27. 4 receptor antagonist SC-41930 on colonic inflammation in rat, guinea pig and rabbit. J Pharmacol ExpTher 1990;255:572-576.
28. 4 potentiates colonic ulceration in the rat. Dig Dis Sci 1990;35: 622-629.
29. Welton AF, Hurley J, Will P: Flavonoids and arachidonic acid metabolism; in Cody V, Middleton Jr. E, Harborne JB, Beretz A (eds): Plant Flavonoids in Biology and Medicine. Vol II: Biochemical, Cellular, and Medicinal Properties, New York, Liss, 1988, pp 301-312.
30. Yamada T, Grisham MB: Pathogenesis of tissue injury: role of reactive metabolites of oxygen and nitrogen; in Targan SR, Shanahan F (eds): Inflammatory Bowel Disease: From Bench to Bedside. Baltimore, Williams & Wilkins, 1994, pp 133-150.
31. Loguericio C, D'Argenio G, Delle Cave M, Cosenza V, Della Valle N, Mazzacca G, Blanco CV: Direct evidence of oxidative damage in acute and chronic phases of experimental colitis in rats. Dig Dis Sci 1996;41: 1204-1211.
32. Lih-Brody L, Powell SR, Collier KP, Reddy GM, Cerchia R, Kahn E, Weissman GS, Katz S, Floyd RA, McKinley MJ, Fisher SE, Mullin GE: Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease. Dig Dis Sci 1996;41:2078-2086.
33. Beutler E: Nutritional and metabolic aspects of glutathione. Annu Rev Nutr 1989;9:287-302.
34. Lauterburg BH, Bilzer M, Rowedder E, Inauen W: Decreased glutathione in inflamed colonic mucosa in man. A possible role of hypochlorous acid and prevention by 5-aminosalicylic acid; in MacDermott (ed): Inflammatory Bowel Disease: Current Status and Future Approach. Amsterdam, Elsevier Science, 1988, pp 273-277.